Fundz

Japanese dental startup Toregem raises $5.3 M in Pre-Series C funding to treat congenital tooth agenesis with TRG035, led by JIC Venture Growth Investments.

PRIVATEJun 02, 2026

Amount Raised

$5.3 Million

Round Type

Venture

JapanBiotechnologyHealth CareTherapeutics

Investors

JIC Venture Growth Investments

Description

Japan-based startup Toregem BioPharma has raised approximately $5.3 million in a Pre-Series C financing round. This round involved new investors through J-KISS-type stock acquisition rights and third-party allotments. The funding will support Phase II clinical trials of TRG035, a humanised anti-USAG-1 antibody. Toregem aims to accelerate its clinical development and obtain approval for new treatment in Japan.

Quick answer

Toregem raised $5.3 Million in a funding round, dated June 2, 2026. Investors: JIC Venture Growth Investments. Toregem is based in Japan.

How much did Toregem raise?
Toregem raised $5.3 Million in a funding round on June 2, 2026.
Who invested in Toregem?
JIC Venture Growth Investments is named as investors in this round.
What does Toregem do?
Toregem is a Japanese dental startup focused on developing innovative treatments for congenital tooth agenesis.
Where is Toregem based and how big is it?
Toregem is based in Japan. Fundz records about 2 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Toregem that raised within 45 days of this round, from Fundz verified event records.

  • ME Therapeutics Holdings raised $457K (Post-IPO Equity) on July 17, 2026.
  • Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
  • Georgiamune raised $93M on July 16, 2026.
  • Crescent Biopharma raised $8.1M (Post-IPO Equity) on July 15, 2026.
  • AdvanCell raised $315M (Series D) on July 15, 2026.
  • Draig Therapeutics raised $65M (Series B) on July 14, 2026.

Who to call at Toregem, and when

A new round usually means Toregem is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Toregem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Toregem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Toregem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Toregem

Location

Japan

About

Toregem is a Japanese dental startup focused on developing innovative treatments for congenital tooth agenesis. Their lead product, TRG035, is a humanised anti-USAG-1 antibody designed to provide a new therapeutic option for patients with limited alternatives. The company aims to enhance clinical development and pursue approvals for its treatment in Japan and the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Toregem raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Toregem's next move

See what Strategic adds

Toregem raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.